investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Genetic Modifiers of Initiation and Progression of Mammary Cancer

Kent Hunter

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Thomas Keane

Wellcome Trust Sanger Institute (WT)

Saffron Walden, United Kingdom

David Adams

Wellcome Trust Sanger Institute (WT)

Saffron Walden, United Kingdom

Kent Hunter

National Cancer Institute (NIH)

Rockville, United States

Related projects

Philip N Tsichlis

The role of IWS1 in development and tumorigenesis

Breast

Zihua Gong

Targeting the DNA repair pathway choice in breast cancer treatment

Breast

David E Goldgar

A Comprehensive Approach to Breast Cancer Susceptibility Across the Risk Spectrum

Breast

Christopher B Umbricht

Multicenter Genetic, Epigenetic and Expression Analysis of DCIS outcome predictors

Breast

Angela Parrish

Axin-induced Wnt signaling in mouse embryogenesis and Wnt-related cancers

Breast

Richard G Pestell

Impact of Cyclin D1 Isoforms in Breast Cancer

Breast

Thomas Spies

Stimulation of Tumorigenesis by NKG2D

Breast

Pathology

Julie Secombe

Distinct Modes of Gene Regulation by KDM5

Breast

Bing Xia

Role of PALB2 in the DNA Damage Response and Cancer Suppression

Breast